Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism

Emerging treatment options for uterine fibroids

(2018) Jacques Donnez et al.   EXPERT OPINION ON EMERGING DRUGS

The Epidemiology and Genetics of Uterine Leiomyoma

(2016) Aaron K. Styer et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells

(2016) Francesca De Amicis et al.   Oncotarget

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression

(2016) Rong Liu et al.   Theranostics

Uterine fibroids

(2016) Elizabeth A. Stewart et al.   Nature Reviews Disease Primers

Roles of Progesterone Receptor A and B Isoforms During Human Endometrial Decidualization

(2015) Hatice S. Kaya et al.   MOLECULAR ENDOCRINOLOGY

Norcantharidin induces autophagy-related prostate cancer cell death through Beclin-1 upregulation by miR-129-5p suppression

(2015) Wenjun Xiao et al.   TUMOR BIOLOGY

Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil

(2015) Liyuan Wan et al.   Oncotarget

Selective Progesterone Receptor Modulator(ulipristal acetate – a new option in the pharmacological treatment of uterine fibroids in women

(2015) Marian Szamatowicz et al.   Ginekologia Polska

Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology

(2015) Maciej Brązert et al.   Ginekologia Polska

Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer

(2013) J. Julie Kim et al.   ENDOCRINE REVIEWS

Borrelidin has limited anti-cancer effects in bcl-2 overexpressing breast cancer and leukemia cells and reveals toxicity in non-malignant breast epithelial cells

(2013) Diana Gafiuc et al.   JOURNAL OF APPLIED TOXICOLOGY

Uterine Leiomyoma: Available Medical Treatments and New Possible Therapeutic Options

(2013) Md. Soriful Islam et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Truncated Progesterone Receptor (PR-M) Localizes to the Mitochondrion and Controls Cellular Respiration

(2013) Qunsheng Dai et al.   MOLECULAR ENDOCRINOLOGY

Decreased expression of Beclin-1 and LC3 in human lung cancer

(2011) Zi-Feng Jiang et al.   MOLECULAR BIOLOGY REPORTS

Transcription Factor KLF11 Integrates Progesterone Receptor Signaling and Proliferation in Uterine Leiomyoma Cells

(2010) P. Yin et al.   CANCER RESEARCH

Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma

(2010) Hiroshi Ishikawa et al.   ENDOCRINOLOGY

Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial

(2009) M. Engman et al.   HUMAN REPRODUCTION